Dna Group (T.R.) Ltd (DNA.TA)
ILA 116.2
(6.02%)
ILA 116.2
(6.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -678 Thousand | -354 Thousand | -2.33 Million | -611 Thousand | -1.37 Million | -1.66 Million |
| Net Income | -1.17 Million | -23.53 Million | 18.37 Million | -19.26 Million | -38.53 Million | -14.28 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 67 Thousand | 973 Thousand | 3.42 Million | 445 Thousand | 1.26 Million | 116 Thousand |
| Change in working capital | -453 Thousand | 1.61 Million | -897 Thousand | 536 Thousand | -223 Thousand | 339 Thousand |
| Other non-cash items | 885 Thousand | 18.14 Million | -20.78 Million | 17.67 Million | 36.12 Million | 12.17 Million |
| Investing Cash Flow | 1.29 Million | 854 Thousand | -1.42 Million | - | -2.02 Million | 636 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | -2.8 Million | - |
| Investment purchases | - | -2.14 Million | -2.14 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.29 Million | 2.99 Million | 719 Thousand | - | 775 Thousand | 636 Thousand |
| Financing Cash Flow | - | 41.05 Million | 27.4 Million | 280 Thousand | 3.28 Million | - |
| Debt repayment | - | - | - | -280 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 41.05 Million | 27.4 Million | - | 3.28 Million | - |
| Other Financing Activities | - | 41.05 Million | 27.4 Million | 280 Thousand | 3.28 Million | - |
| Accounts receivables | -42 Thousand | 22 Thousand | -186 Thousand | -15 Thousand | - | 65 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -411 Thousand | 1.59 Million | -711 Thousand | 551 Thousand | - | - |
| Cash at beginning of period | 65.72 Million | 23.69 Million | 42 Thousand | 373 Thousand | 492 Thousand | 1.51 Million |
| Cash at end of period | 66.69 Million | 65.72 Million | 23.69 Million | 42 Thousand | 373 Thousand | 492 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 351 Thousand | 488 Thousand | 488 Thousand | - | - | - |
| Net cash flow / Change in cash | 969 Thousand | 42.03 Million | 23.64 Million | -331 Thousand | -119 Thousand | -1.02 Million |
| Free Cash Flow | -678 Thousand | -354 Thousand | -2.33 Million | -611 Thousand | -1.37 Million | -1.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.38 Million | 9.38 Million | -1.17 Million | -1.86 Million | -1.86 Million | 1.27 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 61 Thousand | 61 Thousand | 67 Thousand | 117.5 Thousand | 117.5 Thousand | -84 Thousand |
| Change in working capital | 33 Thousand | 33 Thousand | -453 Thousand | 1500.00 | 1500.00 | -22.5 Thousand |
| Other non-cash items | -9.26 Million | -9.26 Million | 885 Thousand | 1.66 Million | 1.66 Million | -1.43 Million |
| Investing Cash Flow | - | - | 1.29 Million | - | - | 648 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 1.29 Million | - | - | 648 Thousand |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 33 Thousand | 33 Thousand | -42 Thousand | 1500.00 | 1500.00 | -22.5 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -411 Thousand | - | - | -216 Thousand |
| Cash at beginning of period | - | - | 65.72 Million | - | - | 65.72 Million |
| Cash at end of period | 216 Thousand | 216 Thousand | 66.69 Million | -152 Thousand | -152 Thousand | 67 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 351 Thousand | -78 Thousand | -78 Thousand | 253.5 Thousand |
| Net cash flow / Change in cash | 216 Thousand | 216 Thousand | 969 Thousand | -152 Thousand | -152 Thousand | 1.27 Million |
| Free Cash Flow | 216 Thousand | 216 Thousand | -678 Thousand | -74 Thousand | -74 Thousand | -265 Thousand |
1322
CU
SHLT
AISPW
009680
XOMAO